Prostate Cancer - Results from #24340

Androgen deprivation therapy for prostate cancer and osteoporotic risk - Abstract November 27, 2012

Urinary continence following laparoscopic radical prostatectomy: Qualitative analysis - Abstract November 27, 2012

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy - Abstract November 27, 2012

Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: Significance in clinicopathological outcomes following radical prostatectomy - Abstract November 27, 2012

Progress in emerging therapies for advanced prostate cancer - Abstract November 27, 2012

Socioeconomic and clinical factors influence the interval between positive prostate biopsy and radical prostatectomy - Abstract November 27, 2012

Prostate cancers of different zonal origin: Clinicopathological characteristics and biochemical outcome after radical prostatectomy - Abstract November 27, 2012

Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance - Abstract November 27, 2012

Free prostate-specific antigen is a better tool than total prostate-specific antigen at predicting prostate volume in patients with lower urinary tract symptoms - Abstract November 27, 2012

Interactive Case-Lecture Series - Advances in Treating Metastatic Castration Resistant Prostate Cancer November 27, 2012

Treatment of chemotherapy-naive metastatic castration-resistant prostate cancer - Case Lecture Presentation November 26, 2012

Metabolic impact of androgen deprivation therapy for prostate cancer - Abstract November 26, 2012

MRI-guided targeted prostate biopsies in the diagnosis of prostate cancer: A systematic literature review - Abstract November 24, 2012

Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: A meta-analysis - Abstract November 24, 2012

25 Year disease free survival rate after irradiation of prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy - Abstract November 24, 2012

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate c November 24, 2012

Are Partin tables suitable for Chinese patients with prostate cancer? - Abstract November 24, 2012

Diagnostic tests in urology: Percentage of free prostate-specific antigen (PSA) - Abstract November 24, 2012

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: An international comparison - Abstract November 24, 2012

Repeat transrectal prostate biopsies in diagnosing prostate cancer - Abstract November 23, 2012

Page 1218 of 1436